Literature DB >> 1817725

Chromogranin A: localization and stoichiometry in large dense core catecholamine storage vesicles from sympathetic nerve.

D T O'Connor1, R L Klein, A K Thureson-Klein, J A Barbosa.   

Abstract

Chromogranin A is present in both adrenal medullary chromaffin granules and sympathetic nerve large dense core catecholamine storage vesicles (LDVs), yet selective stimulation of sympathetic axons provokes only minor changes in chromogranin A in the circulation. We therefore examined the stoichiometry of chromogranin A storage in purified LDVs as compared to chromaffin granules. Chromogranin A was found in LDVs on immunocytochemical sections of sympathetic axons. Sedimentation of sympathetic axon homogenates on sucrose-D2O gradients localized chromogranin A, norepinephrine, enkephalins and dopamine-beta-hydroxylase to the same gradient particulate fractions, suggesting that they inhabit a particle of the same buoyant density, the LDV. Chromogranin A was identified in LDV by radioimmunoassay, immunoblotting and immunocytochemistry. Purified LDVs contained 17.8 +/- 4.8% of cell total chromogranin A, at 27.9 +/- 3.5-fold enrichment over the original axon homogenate. When LDVs were lysed, all of the chromogranin A immunoreactivity originated from the soluble vesicle core rather than the LDV membrane. Although chromogranin A/catecholamine ratios were similar in LDVs and adrenal chromaffin granules, chromogranin A was a quantitatively minor protein in LDVs, accounting for only 0.16 +/- 0.015% of total LDV protein, as compared to 35.2 +/- 1.4% of total chromaffin granule protein. Each LDV particle contained approximately 0.94 +/- 0.09 chromogranin A molecules. Immunocytochemical data suggested that chromogranin A is costored in large dense core noradrenergic vesicles in subpopulations of sympathetic axons, analogous to enkephalins and neuropeptide Y. Thus, only profound changes in exocytotic catecholamine release from sympathetic axon LDVs would be expected to perturb circulating chromogranin A concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1817725     DOI: 10.1016/0006-8993(91)90795-w

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Dual ultrastructural localization of mu-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens.

Authors:  K N Gracy; A L Svingos; V M Pickel
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

2.  Deletion of tyrosine hydroxylase gene reveals functional interdependence of adrenocortical and chromaffin cell system in vivo.

Authors:  S R Bornstein; H Tian; A Haidan; A Böttner; N Hiroi; G Eisenhofer; S M McCann; G P Chrousos; S Roffler-Tarlov
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

3.  Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses.

Authors:  Sucheta M Vaingankar; Ying Li; Nilima Biswas; Jiaur Gayen; Sonia Choksi; Fangwen Rao; Michael G Ziegler; Sushil K Mahata; Daniel T O'Connor
Journal:  J Hypertens       Date:  2010-04       Impact factor: 4.844

4.  The Leydig cell of the human testis--a new member of the diffuse neuroendocrine system.

Authors:  M S Davidoff; W Schulze; R Middendorff; A F Holstein
Journal:  Cell Tissue Res       Date:  1993-03       Impact factor: 5.249

5.  Chromogranin B: intra- and extra-cellular mechanisms to regulate catecholamine storage and release, in catecholaminergic cells and organisms.

Authors:  Kuixing Zhang; Nilima Biswas; Jiaur R Gayen; Jose Pablo Miramontes-Gonzalez; C Makena Hightower; Maja Mustapic; Manjula Mahata; Chun-Teng Huang; Vivian Y Hook; Sushil K Mahata; Sucheta Vaingankar; Daniel T O'Connor
Journal:  J Neurochem       Date:  2013-11-25       Impact factor: 5.372

6.  Decreased plasma Chromogranin A361-372 (Catestatin) but not Chromogranin A17-38 (Vasostatin) in female dogs with bacterial uterine infection (pyometra).

Authors:  Supranee Jitpean; Mats Stridsberg; Ann Pettersson; Odd V Höglund; Bodil Ström Holst; Ragnvi Hagman
Journal:  BMC Vet Res       Date:  2015-01-31       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.